IBDEI0LC ; ; 06-AUG-2015
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;JUN 29, 2015
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,10113,1,4,0)
 ;;=4^346.10
 ;;^UTILITY(U,$J,358.3,10113,2)
 ;;=^336876
 ;;^UTILITY(U,$J,358.3,10114,0)
 ;;=346.11^^44^561^60
 ;;^UTILITY(U,$J,358.3,10114,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10114,1,3,0)
 ;;=3^Migraine w/o Aura,Intractable
 ;;^UTILITY(U,$J,358.3,10114,1,4,0)
 ;;=4^346.11
 ;;^UTILITY(U,$J,358.3,10114,2)
 ;;=^336829
 ;;^UTILITY(U,$J,358.3,10115,0)
 ;;=346.20^^44^561^65
 ;;^UTILITY(U,$J,358.3,10115,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10115,1,3,0)
 ;;=3^Migraine,Cluster,Not Intractable
 ;;^UTILITY(U,$J,358.3,10115,1,4,0)
 ;;=4^346.20
 ;;^UTILITY(U,$J,358.3,10115,2)
 ;;=^336877
 ;;^UTILITY(U,$J,358.3,10116,0)
 ;;=346.21^^44^561^64
 ;;^UTILITY(U,$J,358.3,10116,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10116,1,3,0)
 ;;=3^Migraine,Cluster,Intractable
 ;;^UTILITY(U,$J,358.3,10116,1,4,0)
 ;;=4^346.21
 ;;^UTILITY(U,$J,358.3,10116,2)
 ;;=^336830
 ;;^UTILITY(U,$J,358.3,10117,0)
 ;;=346.80^^44^561^66
 ;;^UTILITY(U,$J,358.3,10117,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10117,1,3,0)
 ;;=3^Migraine,Ophthalmic
 ;;^UTILITY(U,$J,358.3,10117,1,4,0)
 ;;=4^346.80
 ;;^UTILITY(U,$J,358.3,10117,2)
 ;;=^336878
 ;;^UTILITY(U,$J,358.3,10118,0)
 ;;=350.1^^44^561^37
 ;;^UTILITY(U,$J,358.3,10118,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10118,1,3,0)
 ;;=3^Fifth Nerve Palsy
 ;;^UTILITY(U,$J,358.3,10118,1,4,0)
 ;;=4^350.1
 ;;^UTILITY(U,$J,358.3,10118,2)
 ;;=^121978
 ;;^UTILITY(U,$J,358.3,10119,0)
 ;;=351.9^^44^561^15
 ;;^UTILITY(U,$J,358.3,10119,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10119,1,3,0)
 ;;=3^CN VII Palsy
 ;;^UTILITY(U,$J,358.3,10119,1,4,0)
 ;;=4^351.9
 ;;^UTILITY(U,$J,358.3,10119,2)
 ;;=^109776
 ;;^UTILITY(U,$J,358.3,10120,0)
 ;;=356.9^^44^561^101
 ;;^UTILITY(U,$J,358.3,10120,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10120,1,3,0)
 ;;=3^Peripheral Neuropathy
 ;;^UTILITY(U,$J,358.3,10120,1,4,0)
 ;;=4^356.9
 ;;^UTILITY(U,$J,358.3,10120,2)
 ;;=^123931
 ;;^UTILITY(U,$J,358.3,10121,0)
 ;;=357.0^^44^561^43
 ;;^UTILITY(U,$J,358.3,10121,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10121,1,3,0)
 ;;=3^Guillain-Barre Syndrome
 ;;^UTILITY(U,$J,358.3,10121,1,4,0)
 ;;=4^357.0
 ;;^UTILITY(U,$J,358.3,10121,2)
 ;;=^2622
 ;;^UTILITY(U,$J,358.3,10122,0)
 ;;=358.00^^44^561^69
 ;;^UTILITY(U,$J,358.3,10122,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10122,1,3,0)
 ;;=3^Myasthenia Gravis
 ;;^UTILITY(U,$J,358.3,10122,1,4,0)
 ;;=4^358.00
 ;;^UTILITY(U,$J,358.3,10122,2)
 ;;=^329920
 ;;^UTILITY(U,$J,358.3,10123,0)
 ;;=363.01^^44^561^39
 ;;^UTILITY(U,$J,358.3,10123,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10123,1,3,0)
 ;;=3^Focal Choroiditis/Choriorentinitis
 ;;^UTILITY(U,$J,358.3,10123,1,4,0)
 ;;=4^363.01
 ;;^UTILITY(U,$J,358.3,10123,2)
 ;;=^268664
 ;;^UTILITY(U,$J,358.3,10124,0)
 ;;=363.05^^44^561^70
 ;;^UTILITY(U,$J,358.3,10124,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10124,1,3,0)
 ;;=3^Neuroretinitis
 ;;^UTILITY(U,$J,358.3,10124,1,4,0)
 ;;=4^363.05
 ;;^UTILITY(U,$J,358.3,10124,2)
 ;;=^268667
 ;;^UTILITY(U,$J,358.3,10125,0)
 ;;=367.21^^44^561^11
 ;;^UTILITY(U,$J,358.3,10125,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10125,1,3,0)
 ;;=3^Astigmatism
 ;;^UTILITY(U,$J,358.3,10125,1,4,0)
 ;;=4^367.21
 ;;^UTILITY(U,$J,358.3,10125,2)
 ;;=^265371
 ;;^UTILITY(U,$J,358.3,10126,0)
 ;;=367.52^^44^561^77
 ;;^UTILITY(U,$J,358.3,10126,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10126,1,3,0)
 ;;=3^Ophthalmoplegia,Internal
 ;;^UTILITY(U,$J,358.3,10126,1,4,0)
 ;;=4^367.52
 ;;^UTILITY(U,$J,358.3,10126,2)
 ;;=^265383
 ;;^UTILITY(U,$J,358.3,10127,0)
 ;;=367.53^^44^561^4
 ;;^UTILITY(U,$J,358.3,10127,1,0)
 ;;=^358.31IA^4^2
 ;;
 ;;$END ROU IBDEI0LC
